Moolec Science SA (NASDAQ:MLECW) Short Interest Down 93.1% in April

Moolec Science SA (NASDAQ:MLECW) saw a significant decrease in short interest in April. As of April 15th, there was short interest totaling 129 shares, a decrease of 93.1% from the March 31st total of 1,880 shares. Based on an average daily trading volume, of 328,708 shares, the short-interest ratio is currently 0.0 days.

Moolec Science Price Performance

MLECW stock traded up $0.00 during trading on Friday, reaching $0.02. The company had a trading volume of 54,625 shares, compared to its average volume of 803,143. Moolec Science has a 52 week low of $0.00 and a 52 week high of $0.16. The business has a 50 day moving average of $0.03 and a 200 day moving average of $0.02.

Moolec Science Company Profile

Moolec Science is a biotechnology company focused on developing gene-edited livestock as living bioreactors to produce therapeutic proteins. The company leverages CRISPR/Cas9 and related gene-editing technologies to introduce human genes into the genome of pigs, enabling the secretion of complex human proteins in sow’s milk. By combining advanced genetic engineering with traditional livestock breeding, Moolec Science aims to address scalability and cost challenges associated with conventional biologics manufacturing.

The company’s pipeline centers on the production of large multimolecular proteins, including coagulation factors and antibody fragments, for rare diseases and life-threatening conditions.